Evidence map›Paper›PMID 31262249›Full record

ArticleBMC bioinformatics2019

Polled Digital Cell Sorter (p-DCS): Automatic identification of hematological cell types from single cell RNA-sequencing clusters.

Sergii Domanskyi, Anthony Szedlak, Nathaniel T Hawkins, Jiayin Wang, Giovanni Paternostro, Carlo Piermarocchi

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. celltypeEnrich: a consensus-based scRNA-seq cluster annotation tool.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Mapping Cell Identity from scRNA-seq: A primer on computational methods.Computational and structural biotechnology journal · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Automatic cell type identification methods for single-cell RNA sequencing.Computational and structural biotechnology journal · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Modeling disease progression in Multiple Myeloma with Hopfield networks and single-cell RNA-seq.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2019
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sergii DomanskyiDepartment of Physics and Astronomy, Michigan State University, East Lansing, MI, 48824, USA. domansk6@msu.edu.ORCID http://orcid.org/0000-0002-6847-6019
Anthony SzedlakDepartment of Physics and Astronomy, Michigan State University, East Lansing, MI, 48824, USA.
Nathaniel T HawkinsDepartment of Physics and Astronomy, Michigan State University, East Lansing, MI, 48824, USA.
Jiayin WangSalgomed, Inc., Del Mar, CA, 92014, USA.
Giovanni PaternostroSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Carlo PiermarocchiDepartment of Physics and Astronomy, Michigan State University, East Lansing, MI, 48824, USA.

Funding

Data-driven models of hematological cell fate decision and differentiationR01GM122085 · NIGMS · MICHIGAN STATE UNIVERSITY · PI PIERMAROCCHI, CARLO · 2016 to 2020
$1.8M
NIGMS NIH HHS R01 GM122085NIGMS NIH HHS R01GM122085
6 · The paper itself

Abstract

backgroundSingle cell RNA sequencing (scRNA-seq) brings unprecedented opportunities for mapping the heterogeneity of complex cellular environments such as bone marrow, and provides insight into many cellular processes. Single cell RNA-seq has a far larger fraction of missing data reported as zeros (dropouts) than traditional bulk RNA-seq, and unsupervised clustering combined with Principal Component Analysis (PCA) can be used to overcome this limitation. After clustering, however, one has to interpret the average expression of markers on each cluster to identify the corresponding cell types, and this is normally done by hand by an expert curator.

resultsWe present a computational tool for processing single cell RNA-seq data that uses a voting algorithm to automatically identify cells based on approval votes received by known molecular markers. Using a stochastic procedure that accounts for imbalances in the number of known molecular signatures for different cell types, the method computes the statistical significance of the final approval score and automatically assigns a cell type to clusters without an expert curator. We demonstrate the utility of the tool in the analysis of eight samples of bone marrow from the Human Cell Atlas. The tool provides a systematic identification of cell types in bone marrow based on a list of markers of immune cell types, and incorporates a suite of visualization tools that can be overlaid on a t-SNE representation. The software is freely available as a Python package at https://github.com/sdomanskyi/DigitalCellSorter .

conclusionsThis methodology assures that extensive marker to cell type matching information is taken into account in a systematic way when assigning cell clusters to cell types. Moreover, the method allows for a high throughput processing of multiple scRNA-seq datasets, since it does not involve an expert curator, and it can be applied recursively to obtain cell sub-types. The software is designed to allow the user to substitute the marker to cell type matching information and apply the methodology to different cellular environments.

Indexed as

SoftwareAlgorithmsBone Marrow CellsCluster AnalysisGene Expression ProfilingHumansPrincipal Component AnalysisSequence Analysis, RNASingle-Cell AnalysisBiomarkersBone marrowCell type identificationSingle cell RNA sequencing

Identifiers

PMID31262249
PMCPMC6604348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.